{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:37:10Z","timestamp":1790303830539,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s13139-023-00793-7","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:39:22Z","timestamp":1677757162000},"page":"206-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidental Detection of Papillary Thyroid Carcinoma in Tc-99\u00a0m PSMA Imaging in a Case with Negative FNA Result"],"prefix":"10.1007","volume":"57","author":[{"given":"Maryam","family":"Abdinejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-6609","authenticated-orcid":false,"given":"Tahereh","family":"Ghaedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"793_CR1","doi-asserted-by":"crossref","unstructured":"Sheikhbahaei S, Werner RA, Solnes LB, Pienta KJ, Pomper MG, Gorin MA, et al. Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls. Semin Nucl Med. 2019;49:255\u201370.","DOI":"10.1053\/j.semnuclmed.2019.02.006"},{"key":"793_CR2","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1007\/s00259-021-05433-w","volume":"48","author":"M Uijen","year":"2021","unstructured":"Uijen M, Derks Y, Merkx R, Schilham M, Roosen J, Priv\u00e9 B, et al. PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports. Eur J Nucl Med Mol Imaging. 2021;48:4350\u201368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"793_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s42000-019-00106-8","volume":"18","author":"F Bertagna","year":"2019","unstructured":"Bertagna F, Albano D, Giovanella L, Bonacina M, Durmo R, Giubbini R, et al. 68Ga-PSMA PET thyroid incidentalomas. Hormones. 2019;18:145\u20139.","journal-title":"Hormones"},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13000-019-0924-z","volume":"15","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Song Y, Xu G, Fan Z, Ren W. Causes of misdiagnoses by thyroid fine-needle aspiration cytology (FNAC): our experience and a systematic review. Diagn Pathol. 2020;15:1\u20138.","journal-title":"Diagn Pathol"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/jcu.22721","volume":"47","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Kim YJ, Han HY, Seo JY, Hwang CM, Kim K. Ultrasound-guided needle biopsy of large thyroid nodules: core needle biopsy yields more reliable results than fine needle aspiration. J Clin Ultrasound. 2019;47:255\u201360.","journal-title":"J Clin Ultrasound"},{"key":"793_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/hed.25530","volume":"41","author":"HS Ahn","year":"2019","unstructured":"Ahn HS, Na DG, Baek JH, Sung JY, Kim JH. False negative rate of fine-needle aspiration in thyroid nodules: impact of nodule size and ultrasound pattern. Head Neck. 2019;41:967\u201373.","journal-title":"Head Neck"},{"key":"793_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.asjsur.2021.08.005","volume":"45","author":"HK Kim","year":"2022","unstructured":"Kim HK, Kim SY, Lee YS, Soh EY, Chang H-S, Park CS. Suspicious thyroid nodules 4 cm require a diagnostic lobectomy regardless of their benign fine needle aspiration results. Asian J Surg. 2022;45:1113\u20136.","journal-title":"Asian J Surg"},{"key":"793_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1210\/er.2017-00133","volume":"39","author":"EJ de Koster","year":"2018","unstructured":"de Koster EJ, de Geus-Oei L-F, Dekkers OM, van Engen-van GI, Hamming J, Corssmit EP, et al. Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules. Endocr Rev. 2018;39:154\u201391.","journal-title":"Endocr Rev"},{"key":"793_CR9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1007\/s00259-021-05627-2","volume":"49","author":"EJ de Koster","year":"2022","unstructured":"de Koster EJ, de Geus-Oei L-F, Brouwers AH, van Dam EW, Dijkhorst-Oei L-T, van Engen-van Grunsven AC, et al. [18F] FDG-PET\/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial. Eur J Nucl Med Mol Imaging. 2022;49:1970\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00259-015-3065-y","volume":"42","author":"FA Verburg","year":"2015","unstructured":"Verburg FA, Krohn T, Heinzel A, Mottaghy FM, Behrendt FF. First evidence of PSMA expression in differentiated thyroid cancer using 68Ga PSMA-HBED-CC PET\/CT. Eur J Nucl Med Mol Imaging. 2015;42:1622.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"793_CR11","doi-asserted-by":"publisher","first-page":"9867","DOI":"10.18632\/oncotarget.23984","volume":"9","author":"B Heitk\u00f6tter","year":"2018","unstructured":"Heitk\u00f6tter B, Steinestel K, Trautmann M, Gr\u00fcnewald I, Barth P, Gevensleben H, et al. Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid. Oncotarget. 2018;9:9867.","journal-title":"Oncotarget"},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2967\/jnmt.115.171660","volume":"44","author":"S Sager","year":"2016","unstructured":"Sager S, Vatankulu B, Uslu L, S\u00f6nmezoglu K. Incidental detection of follicular thyroid carcinoma in 68Ga-PSMA PET\/CT imaging. J Nucl Med Technol. 2016;44:199\u2013200.","journal-title":"J Nucl Med Technol"},{"key":"793_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-020-00720-3","volume":"10","author":"C Lawhn-Heath","year":"2020","unstructured":"Lawhn-Heath C, Yom SS, Liu C, Villanueva-Meyer JE, Aslam M, Smith R, et al. Gallium-68 prostate-specific membrane antigen ([68 Ga] Ga-PSMA-11) PET for imaging of thyroid cancer: A feasibility study. EJNMMI Res. 2020;10:1\u201310.","journal-title":"EJNMMI Res"},{"key":"793_CR14","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1097\/RLU.0000000000002161","volume":"43","author":"P Verma","year":"2018","unstructured":"Verma P, Malhotra G, Agrawal R, Sonavane S, Meshram V, Asopa RV. Evidence of prostate-specific membrane antigen expression in metastatic differentiated thyroid cancer using 68Ga-PSMA-HBED-CC PET\/CT. Clin Nucl Med. 2018;43:e265\u20138.","journal-title":"Clin Nucl Med"},{"key":"793_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-019-0559-9","volume":"9","author":"M Sollini","year":"2019","unstructured":"Sollini M, di Tommaso L, Kirienko M, Piombo C, Erreni M, Lania AG, et al. PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome. EJNMMI Res. 2019;9:1\u201313.","journal-title":"EJNMMI Res"}],"container-title":["Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-023-00793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13139-023-00793-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-023-00793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T13:53:56Z","timestamp":1689861236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13139-023-00793-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1007\/s13139-023-00793-7","relation":{},"ISSN":["1869-3474","1869-3482"],"issn-type":[{"value":"1869-3474","type":"print"},{"value":"1869-3482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"9 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Maryam Abdinejad and Tahereh Ghaedian declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the institutional review board of Shiraz University of Medical Sciences and according to retrospective design of the study, the requirement for written consent was waived by the institutional review board. All procedures performed in studies involving human participants were in accordance with the Helsinki declaration as revised in 2013 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"The participant signed consent regarding publishing their data (and\/or photographs).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}